title: Are there genetic determinants of olanzapine-induced agranulocytosis?
authors.forename: W
authors.initials: W
authors.lastname: Felber
authors.forename: R
authors.initials: R
authors.lastname: Naumann
authors.forename: U
authors.initials: U
authors.lastname: Schuler
authors.forename: M
authors.initials: M
authors.lastname: Fülle
authors.forename: T
authors.initials: T
authors.lastname: Reuster
authors.forename: K
authors.initials: K
authors.lastname: Garcia
authors.forename: H
authors.initials: H
authors.lastname: Heilemann
mesh_terms: D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000235:genetics*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D015789:HLA-A2 Antigen / Q000235:genetics; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D044469:Racial Groups
chemical_list: D014150:Antipsychotic Agents; D015789:HLA-A2 Antigen; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine